Symbol
| DLK1
| contributors: mct - updated : 06-01-2016
|
HGNC name
| delta-like 1 homolog (Drosophila)
|
HGNC id
| 2907
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in renal cell carcinoma by gain of methylation upstream of the untranslated MEG3 leading to pathological downregulation | tumoral
|  
|  
| --over
|  
|
in GH-secreting (GH-S) pituitary tumors, and in gliomas | tumoral
|  
|  
| --over
|  
|
in hepatocellular carcinoma, through deregulation of genomic DNA methylation of the imprinted domain | |
Susceptibility
|
to type 1 diabetes |
Variant & Polymorphism
|
| |
Candidate gene
| associated with child and adolescent obesity |
Marker
Therapy target
| | |
| transgenic mice overexpressing soluble DLK1 in adipose tissue or liver show a marked decrease in adiposity, with reduced adipogenesis and adipocyte marker expression | |
Dlk1(-/-) mice were developmentally retarded in their muscle mass and function owing to inhibition of the myogenic program during embryogenesis |